Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149,276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study.
Hou J, Jin J, Xu Y, Wu D, Ke X, Zhou D, Lu J, Du X, Chen X, Li J, Liu J, Gupta N, Hanley MJ, Li H, Hua Z, Wang B, Zhang X, Wang H, van de Velde H, Richardson PG, Moreau P. Hou J, et al. Among authors: wang h, wang b. J Hematol Oncol. 2017 Jul 6;10(1):137. doi: 10.1186/s13045-017-0501-4. J Hematol Oncol. 2017. PMID: 28683766 Free PMC article. Clinical Trial.
[Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas].
Wu Y, Wang H, Liu XJ, Wang YY, Zhao WL, Li JM, Shen ZX. Wu Y, et al. Among authors: wang h, wang yy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Aug;25(4):1036-1041. doi: 10.7534/j.issn.1009-2137.2017.04.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28823264 Chinese.
149,276 results
You have reached the last available page of results. Please see the User Guide for more information.